Literature DB >> 17467498

Value-based pricing of drugs in the UK.

David J Webb1, Andrew Walker2.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17467498     DOI： 10.1016/S0140-6736(07)60648-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  UK medicines policy: the role of clinical pharmacologists.

Authors:  David J Webb
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Value-based pricing: incentive for innovation or zero net benefit?

Authors:  Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

Review 3.  Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Authors:  Jakub Adamski; Brian Godman; Gabriella Ofierska-Sujkowska; Bogusława Osińska; Harald Herholz; Kamila Wendykowska; Ott Laius; Saira Jan; Catherine Sermet; Corrine Zara; Marija Kalaba; Roland Gustafsson; Kristina Garuolienè; Alan Haycox; Silvio Garattini; Lars L Gustafsson
Journal:  BMC Health Serv Res       Date:  2010-06-07       Impact factor: 2.655

4.  Application of the Price-Volume Approach in Cases of Innovative Drugs Where Value-Based Pricing is Inadequate: Description of Real Experiences in Italy.

Authors:  Andrea Messori
Journal:  Clin Drug Investig       Date:  2016-08       Impact factor: 2.859

5.  On Conflicts between Pharmaceutical Patent Protection and the Right to Life and Health Based on a Stackelberg Game.

Authors:  Chunming Xu; Debao Zhu
Journal:  Int J Environ Res Public Health       Date:  2021-01-27       Impact factor: 3.390

Review 6.  Using RWE research to extend clinical trials in diabetes: An example with implications for the future.

Authors:  John D Seeger; Anthony Nunes; Anita M Loughlin
Journal:  Diabetes Obes Metab       Date:  2020-04       Impact factor: 6.577

7.  A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency.

Authors:  Afschin Gandjour
Journal:  BMC Health Serv Res       Date:  2020-03-23       Impact factor: 2.655
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.